EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Long‐Term Outcomes of Liver Transplant Recipients. What Do Patients Die From?

Carlos Jiménez-Romero, Alberto Marcacuzco, Oscar Caso, Alejandro Manrique, Alvaro García-Sesma, Jorge Calvo, Anisa Nutu, Enrique Moreno-González, Mercedes Bernaldo de Quirós, Iago Justo Alonso iD

World Journal of Surgery · 2025-06 · 49 (6) · 1632-1642

DOI: 10.1002/wjs.12614 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift World Journal of Surgery, online erschienen am 08.05.2025. Verfasst von Carlos Jiménez-Romero und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Hepato-Pancreato-Biliary Surgery and Abdominal Organ Transplantation, Doce de Octubre University Hospital. Instituto de Investigación Sanitar…. Hauptthemen laut MEDLINE: Liver Transplantation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several advances in liver transplantation (LT) have provided an increased rate in 1‐year patient survival, currently reported between 84.5% and 91.4%. However, this significant improvement is not widely maintained after the 1‐year of follow‐up. In this study, we analyze short‐term and long‐term results in LT recipients.

Methods

A retrospective observational cohort study, including patients who underwent LT between 1990 and 2009 and were followed for a minimum 15‐year period, analyzing the causes and risk factors of mortality and patient and graft survival from LT up to the last outpatient visit.

Results

A total of 594 patients with LT were included (median age, 53‐year and 69.7% male). The most common indications for LT were HCV‐cirrhosis (267 patients), alcoholic cirrhosis (250 patients), and hepatocellular carcinoma (HCC) (144 patients). Post‐LT complications were acute rejection in 44.1%, cardiovascular in 40.6%, chronic kidney disease in 40.1%, hypertension in 22.6%, and de novo tumors in 25.6%. Retransplantation was performed in 40 (6.7%) patients. A total of 388 (65.3%) patients died during a follow‐up over 20 years: 106 (17.8%) in the first year post‐LT; 76 (12.8%) between 2 and 5 years; 75 (12.6%) between 6 and 10 years; 73 (812.3%) between 11 and 15 years; 30 (5%) between 16 and 20 years; and 28 (4.7%) after 20 years. The overall causes of death were infection in 69 (11.6%) patients, cardiovascular complications in 58 (9.8%) patients, pulmonary complications in 8 (1.3%) patients, liver graft failure in 126 (21.2%) patients, HCC recurrence in 15 (2.6%) patients, de novo tumors in 72 (12.1%) patients, and miscellaneous in 40 (6.7%) patients. Rates of actuarial patient survival at 1‐, 3‐, 5‐, 10‐, 15‐, and 20‐year after LT were 82.7%, 75.6%, 70%, 58.6%, 45.2%, and 37.6%, respectively, and actuarial graft survival were 80%, 72.5%, 67.1%, 54.8%, 42.6%, and 34.6%, respectively. Advanced recipient age, blood transfusion, and infection were the main risk factors for patient mortality.

Conclusions

The highest mortality rate was within the first year of LT, and the most common causes of death were hepatic failure, de novo tumors, infection, cardiovascular disease, and HCC recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHumansMaleMiddle AgedFemaleRetrospective StudiesAdultAgedRisk FactorsPostoperative ComplicationsGraft SurvivalFollow-Up StudiesTreatment OutcomeTime FactorsSurvival RateCause of DeathYoung Adult

Stichwörter der Autor:innen

causes of deathcomplicationsde novo tumorsliver transplantationlong‐term outcomesmortality

Autor:innen und Institutionen

  • Unit of Hepato-Pancreato-Biliary Surgery and Abdominal Organ Transplantation, Doce de Octubre University Hospital. Instituto de Investigación Sanitaria Hospital Doce de Octubre (imas12), Madrid, Spain.
  • Department of Surgery, Faculty of Medicine, Complutense University, Madrid, Spain.

ORCID-Profile: Iago Justo Alonso

Zitieren

APA

Jiménez-Romero, C., Marcacuzco, A., Caso, O., Manrique, A., García-Sesma, A., Calvo, J., Nutu, A., Moreno-González, E., Bernaldo de Quirós, M., & Justo Alonso, I. (2025). Long‐Term Outcomes of Liver Transplant Recipients. What Do Patients Die From?. World Journal of Surgery, 49(6), 1632-1642. https://doi.org/10.1002/wjs.12614

Vancouver

Jiménez-Romero C, Marcacuzco A, Caso O, Manrique A, García-Sesma A, Calvo J, et al. Long‐Term Outcomes of Liver Transplant Recipients. What Do Patients Die From?. World Journal of Surgery. 2025;49(6):1632-1642. doi:10.1002/wjs.12614

BibTeX
@article{JimnezRomero2025,
  author = {Jiménez-Romero, Carlos and Marcacuzco, Alberto and Caso, Oscar and Manrique, Alejandro and García-Sesma, Alvaro and Calvo, Jorge and Nutu, Anisa and Moreno-González, Enrique and Bernaldo de Quirós, Mercedes and Justo Alonso, Iago},
  title = {Long‐Term Outcomes of Liver Transplant Recipients. What Do Patients Die From?},
  journal = {World Journal of Surgery},
  year = {2025},
  volume = {49},
  number = {6},
  pages = {1632--1642},
  doi = {10.1002/wjs.12614}
}
Kostenlos starten →